Prediction of activity in eyes with macular neovascularization due to age-related macular degeneration using deep learning
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Prediction of activity in eyes with macular neovascularization due to age-related macular degeneration using deep learning ; day:26 ; month:10 ; year:2023 ; pages:1-3
Eye ; (26.10.2023), 1-3
- Urheber
-
Corradetti, Giulia
Rakocz, Nadav
Chiang, Jeffrey N.
Avram, Oren
Alagorie, Ahmed Roshdy
Nittala, Muneeswar Gupta
Karamat, Ayesha
Boyer, David S.
Sarraf, David
Halperin, Eran
Sadda, SriniVas
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41433-023-02805-4
- URN
-
urn:nbn:de:101:1-2024011511411075362188
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Corradetti, Giulia
- Rakocz, Nadav
- Chiang, Jeffrey N.
- Avram, Oren
- Alagorie, Ahmed Roshdy
- Nittala, Muneeswar Gupta
- Karamat, Ayesha
- Boyer, David S.
- Sarraf, David
- Halperin, Eran
- Sadda, SriniVas
- SpringerLink (Online service)
Ähnliche Objekte (12)
Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
Current Perspectives on Type 3 Macular Neovascularization due to Age-Related Macular Degeneration
Choroidal Modifications Preceding the Onset of Macular Neovascularization in Age-Related Macular Degeneration
Brolucizumab for recalcitrant macular neovascularization in age-related macular degeneration with pigment epithelial detachment
Correction to: Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
Age-related macular degeneration
Growth of nonexudative macular neovascularization in age-related macular degeneration: an indicator of biological lesion activity
Evolution of macular atrophy in eyes with neovascular age-related macular degeneration compared to fellow non-neovascular eyes
Quantitative assessment of choriocapillaris flow deficits and type 1 macular neovascularization growth in age-related macular degeneration
Type 1 neovascularization may confer resistance to geographic atrophy amongst eyes treated for neovascular age-related macular degeneration
Pachychoroid neovasculopathy versus macular neovascularization in age-related macular degeneration with and without shallow irregular pigment epithelial detachment
Mast cells promote choroidal neovascularization in a model of age-related macular degeneration
Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
Current Perspectives on Type 3 Macular Neovascularization due to Age-Related Macular Degeneration
Choroidal Modifications Preceding the Onset of Macular Neovascularization in Age-Related Macular Degeneration
Brolucizumab for recalcitrant macular neovascularization in age-related macular degeneration with pigment epithelial detachment
Correction to: Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
Age-related macular degeneration
Growth of nonexudative macular neovascularization in age-related macular degeneration: an indicator of biological lesion activity
Evolution of macular atrophy in eyes with neovascular age-related macular degeneration compared to fellow non-neovascular eyes
Quantitative assessment of choriocapillaris flow deficits and type 1 macular neovascularization growth in age-related macular degeneration
Type 1 neovascularization may confer resistance to geographic atrophy amongst eyes treated for neovascular age-related macular degeneration
Pachychoroid neovasculopathy versus macular neovascularization in age-related macular degeneration with and without shallow irregular pigment epithelial detachment
Mast cells promote choroidal neovascularization in a model of age-related macular degeneration
Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
Current Perspectives on Type 3 Macular Neovascularization due to Age-Related Macular Degeneration
Choroidal Modifications Preceding the Onset of Macular Neovascularization in Age-Related Macular Degeneration
Brolucizumab for recalcitrant macular neovascularization in age-related macular degeneration with pigment epithelial detachment
Correction to: Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
Age-related macular degeneration
Growth of nonexudative macular neovascularization in age-related macular degeneration: an indicator of biological lesion activity
Evolution of macular atrophy in eyes with neovascular age-related macular degeneration compared to fellow non-neovascular eyes
Quantitative assessment of choriocapillaris flow deficits and type 1 macular neovascularization growth in age-related macular degeneration
Type 1 neovascularization may confer resistance to geographic atrophy amongst eyes treated for neovascular age-related macular degeneration
Pachychoroid neovasculopathy versus macular neovascularization in age-related macular degeneration with and without shallow irregular pigment epithelial detachment